We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

93 hedge funds and large institutions have $425M invested in Five Prime Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 11

275% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 8

31% more funds holding

Funds holding: 71 → 93 (+22)

15% more capital invested

Capital invested by funds: $369M → $425M (+$56M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
93
Holders Change
+22
Holders Change %
+30.99%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
30
Increased
42
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$24.9M
2
State Street
State Street
Massachusetts
+$22.9M
3
Millennium Management
Millennium Management
New York
+$17.8M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.5M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$28.4M
2
SAM
Senzar Asset Management
New York
-$8.98M
3
BI
BVF Inc
California
-$8.16M
4
MSA
Mason Street Advisors
Wisconsin
-$2.65M
5
QF
QVT Financial
New York
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
101
Cubist Systematic Strategies
Connecticut
– -$260K -9,647 Closed
1 2 3 4
5

FPRX Hedge Fund Activity: Q1 2015 in Review

93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2015, worth a combined $425M — up 15% from $369M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new FPRX positions and 8 closed out — a net gain of 22 holders — while 42 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $24.9M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $28.4M sold.

  • 93 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2015, up from 71 in Q4 2014.
  • Funds reported $425M of Five Prime Therapeutics, Inc. stock for Q1 2015, up 15% quarter-over-quarter.
  • 30 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2015 and 8 closed out, a net change of +22 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2015 was Wellington Management Group, an estimated $24.9M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2015 was TPG Group Holdings (SBS) Advisors, an estimated $28.4M sold.

Based on aggregated 13F filings for Q1 2015.